Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18. [electronic resource]
Producer: 20011204Description: 2140-8 p. digitalISSN:- 1530-6860
- Abatacept
- Animals
- Antibodies -- therapeutic use
- Antigens, CD
- Antigens, Differentiation -- biosynthesis
- B-Lymphocytes -- immunology
- CD40 Ligand -- metabolism
- CTLA-4 Antigen
- Cells, Cultured
- Cytokines -- biosynthesis
- Disease Progression
- Female
- Hypersensitivity, Delayed -- therapy
- Immunoconjugates
- Immunoglobulin G -- biosynthesis
- Interleukin-18 -- antagonists & inhibitors
- Kinetics
- Lymphocyte Activation
- Myasthenia Gravis, Autoimmune, Experimental -- immunology
- Rats
- Rats, Inbred Lew
- Receptors, Nicotinic -- immunology
- T-Lymphocytes -- immunology
- Th1 Cells -- immunology
- Transforming Growth Factor beta -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.